Genomic Valley Biotech Share Price

CMP as on29-Jul-21 11:17

₹ 22.50
-1.1 -4.66%

Open

₹ 22.50

Turnover (lac)

Prev. Close

₹ 23.60

Day's Vol (shares)

₹ 5

Day's Range

₹ 22.50
₹ 22.50

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 02-Aug-2021 - -
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2021 ,inter alia, to consider and approve the Un-Audited Financial Results for the quarter and three months ended 30th June, 2021. Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of Archies Limited (Company) in its meeting held today approved the Un-Audited Financial Results (Standalone) for the Quarter and three months ended 30th June, 2021 of the Company as per Indian Accounting Standards (IND-AS) along with the Limited Review Report. Copy of the results along with the Limited Review Report of Statutory Auditors is attached herewith for your perusal. The above information will also be available on the Companys Website, www.genomicvalley.com . The meeting of the Board of Directors commenced on 11:45 A.M. and concluded at 04:00 P.M. (As Per BSE Announcement dated on 10.08.2021)
Board Meeting - 23-Jun-2021 - -
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2021 ,inter alia, to consider and approve the Audited Financial Results for the quarter and year ended 31st March, 2021. Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons has been closed from 01st April, 2021 till 48 hours of declaration of results i.e. 01st July, 2021 (both days inclusive). Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of Genomic Valley Biotech Limited (Company) in its meeting held today approved the Audited Financial Results (Standalone) for the Quarter and Year ended 31st March, 2021 of the Company as per Indian Accounting Standards (IND-AS) along with the Independent Auditors Report. Copy of the results along with the Independent Auditors Report of Statutory Auditors is attached herewith for your perusal. (As per BSE Announcement Dated on 29/06/2021)
Board Meeting - 22-Jun-2021 - -
Pursuant to the Regulation 30 and other applicable Regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of Archies Limited (Company) in its meeting held today approved the authorization of Mr. Yogesh Agrawal, Managing Director, on behalf of the Company, to sell 5.43125 acres of land out of 9.06 acres of land of the company situated at 4 KM Stone, Berri Chhara Road, P.O. Tanda Heri, Tehsil- Bahadurgarh, District- Jhajjar, Haryana - 124507 alongwith all buildings and all temporary & permanent structure appurtenant thereto to One Point Realty Private Limited having Registered Office at 8-D, Hansalaya 15, Barakhamba Road, New Delhi - 110001 through its authorized persons.
Board Meeting - 06-Apr-2021 - -
Pursuant to the Regulation 30 and other applicable Regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that the Board of Directors of the Company has approved the following appointment in the Board Meeting held on today i.e. 06.04.2021 1. Appointment of Mrs. Monisha Meghna (Membership No. A41747) as Company Secretary and Compliance Officer of the Company with effect from 06.04.2021
Board Meeting - 02-Feb-2021 - -
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2021 ,inter alia, to consider and approve In pursuant of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, the 11th February, 2021 at 11:45 A.M. inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and nine months ended 31st December, 2020. Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons has been closed from 01st January, 2021 till 48 hours of declaration of results i.e. 13th February, 2021 (both days inclusive).
Board Meeting - 02-Dec-2020 - -
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/12/2020 ,inter alia, to consider and approve In pursuant of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, the 05th December, 2020 at 11:45 A.M. at the corporate office of the Company at G-74, Pushkar Enclave, Paschim Vihar, Delhi-110063. Pursuant to the Regulation 30 and any other applicable regulations of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors at its meeting held on 05th December, 2020, has approved the resolutions related to Annual General Meeting and approval of Board Report & Notice of Annual General Meeting. (As Per BSE Announcement Dated on 05.12.2020)
Board Meeting - 29-Oct-2020 - -
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2020 ,inter alia, to consider and approve In pursuant of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, the 11th November, 2020 at 11:45 A.M. inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and half year ended 30th September, 2020. Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons has been closed from 01st October, 2020 till 48 hours of declaration of results i.e. 13th November, 2020 (both days inclusive). Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of Archies Limited (Company) in its meeting held today approved the Un-Audited Financial Results (Standalone) for the Quarter and half year ended 30th September, 2020 of the Company as per Indian Accounting Standards (IND-AS) along with the Limited Review Report. Copy of the results along with the Limited Review Report of Statutory Auditors is attached herewith for your perusal. The above information will also be available on the Companys Website, www.genomicvalley.com . The meeting of the Board of Directors commenced on 11:45 A.M. and concluded at 04:30 P.M. (As Per BSE Announcement Dated on 11/11/2020)
Open ZERO Brokerage Demat Account